前立腺がん

The Japanese term 前立腺がん (Zenritsusen-gan) is a compound noun used to describe prostate cancer. To understand this word, we must break it down into its constituent parts: Zenritsu (前立) meaning 'standing in front,' Sen (腺) meaning 'gland,' and Gan (がん) meaning 'cancer.' In a biological context, the prostate gland is positioned just below the bladder and in front of the rectum, which explains the descriptive nature of the Japanese naming convention. This term is primarily used in medical, health, and social contexts, particularly when discussing men's health issues, aging, and oncology. In Japan, which has one of the world's fastest-aging populations, this word appears frequently in health check-up results, news reports regarding public figures, and pharmaceutical advertisements. While the topic is medical, the word itself is common enough that most Japanese adults, especially those over forty, are intimately familiar with it. It is not considered a 'taboo' word, but it is handled with the typical gravity associated with any cancer diagnosis.

Medical Classification

前立腺がん is classified as a malignant neoplasm (悪性腫瘍) of the male reproductive system.

When using this word, it is important to note that the 'gan' part is often written in hiragana (がん) or katakana (ガン) rather than the complex kanji 癌. This is a common practice in Japanese medical communication to make the word appear less intimidating or simply because the kanji is outside the standard Jōyō list. However, in formal medical journals, you will still encounter the kanji form. The word is often paired with verbs like 見つかる (mitsukaru - to be found) or 診断される (shindan sareru - to be diagnosed). For English speakers, the pronunciation is relatively straightforward: Zen-rit-su-sen-gan. The 'u' in 'ritsu' is often devoiced, sounding like 'zen-rit-sen-gan' in fast speech.

Culturally, the word carries a nuance of 'early detection' (早期発見). Because prostate cancer often progresses slowly, Japanese health campaigns heavily emphasize the word in the context of 'Ningen Dock' (comprehensive health exams). You will see it on brochures in waiting rooms and in the health section of newspapers. In social settings, men might discuss their Zenritsusen health with peers as they age, though usually in a semi-private or serious tone. It represents a significant part of the 'Silver Democracy' health discourse in Japan, as the government seeks to manage the costs of an aging society by promoting awareness of this specific disease.

Common Collocation

前立腺がん検診 (Zenritsusen-gan kenshin) - Prostate cancer screening.

Furthermore, the word is used to differentiate from 'Benign Prostatic Hyperplasia' (前立腺肥大症 - Zenritsusen hidaishō), which is a non-cancerous enlargement of the prostate. Distinguishing between these two is a common point of discussion in Japanese urology clinics. Understanding 前立腺がん is essential for anyone navigating the Japanese healthcare system or translating medical documents. It is a word that bridges the gap between specialized medical terminology and everyday health literacy. By learning this word, you also gain the building blocks for other medical terms, such as Nyūgan (breast cancer) or Igan (stomach cancer), as the suffix -gan remains consistent across most oncology-related vocabulary.

Register Note

While medical, it is the standard term used by both doctors and laypeople. There is no 'slang' for this condition.

Using 前立腺がん (Zenritsusen-gan) in a sentence requires an understanding of Japanese medical grammar and social etiquette. Since cancer is a sensitive topic, the level of formality (keigo) often shifts depending on who is speaking. In a clinical setting, a doctor might use the passive form shindan saremashita (was diagnosed) to convey the news to a patient. For example: "Kensa no kekka, zenritsusen-gan to shindan saremashita" (As a result of the tests, you have been diagnosed with prostate cancer). This usage is direct yet professional. In contrast, if a person is talking about their own health to a friend, they might say "Zenritsusen-gan ni natchatte" (I ended up getting prostate cancer), using the more casual -chau form to express regret or the unfortunate nature of the situation.

Sentence Structure: Diagnosis

[Subject] + は + 前立腺がん + と + 診断された。
(Subject was diagnosed with prostate cancer.)

When discussing treatment, the word is often the object of the sentence. Common verbs include 治療する (chiryō suru - to treat) and 克服する (kokufuku suru - to overcome/beat). For instance, "Chichi wa zenritsusen-gan no chiryō o ukete imasu" (My father is receiving treatment for prostate cancer). Here, the particle no connects the disease to the treatment, creating a noun phrase. It is also common to see the word in the context of prevention and screening. Phrases like "Zenritsusen-gan no risk" (risk of prostate cancer) or "Zenritsusen-gan no yobō" (prevention of prostate cancer) are standard in health literature. The word acts as a standard noun and does not change its form regardless of its position in the sentence.

In more advanced grammatical structures, 前立腺がん can be part of a conditional clause. For example: "Moshi zenritsusen-gan da to shitara, dō shimasu ka?" (If it were prostate cancer, what would you do?). This uses the da to shitara construction to pose a hypothetical scenario. In journalistic writing, the word is frequently seen in statistics. You might read "Zenritsusen-gan no kanjazu ga kyūzō shite iru" (The number of prostate cancer patients is surging). Here, the focus is on the noun as a data point. The flexibility of the word allows it to be used in both highly technical medical discussions and more general public health discourse without any change in meaning.

Sentence Structure: Treatment

前立腺がん + の + 手術 + を + 受ける。
(To undergo surgery for prostate cancer.)

Finally, consider the use of honorifics when discussing the illness of a superior or a client. Instead of just saying the person has the disease, one might say "Zenritsusen-gan o wazuratte irasshaimasu" (He is suffering from prostate cancer), where wazurau (to suffer from an illness) and the honorific irassharu elevate the tone. This is crucial in business or formal social contexts in Japan, where directness about illness can sometimes be perceived as too blunt. By mastering these variations, a learner can navigate various social strata while discussing this common medical condition.

Important Verb

転移する (Ten'i suru) - To metastasize. Often used as 'Hone ni ten'i shita' (Metastasized to the bone).

You will encounter 前立腺がん (Zenritsusen-gan) in several specific environments in Japan. The most common is the Byōin (hospital) or Kurinniku (clinic), particularly in the Hinyōkika (Urology department). If you are in a waiting room, you will see pamphlets titled 'Understanding Prostate Cancer' or 'PSA Screening Information.' Doctors use the term daily when explaining lab results to patients. Because Japan has a system of mandatory annual health checks for employees (Kenkō Shindan), many men over 50 will hear this word during their post-exam consultations if their PSA levels are slightly elevated. It is a word that triggers a specific 'medical protocol' in the minds of Japanese listeners.

Media Presence

NHK's health programs like 'Kyō no Kenkō' (Today's Health) frequently feature episodes dedicated to this topic.

Television is another major source. In Japan, health-related variety shows are extremely popular among the elderly. These programs often feature 'expert doctors' who discuss the latest treatments for 前立腺がん, such as heavy-ion radiotherapy or robotic-assisted surgery. When a famous actor or politician is diagnosed with the disease, it becomes a top news story. For example, when the late Emperor Akihito was diagnosed with prostate cancer in the early 2000s, the word was broadcast daily, leading to a massive surge in public awareness and screening rates. In this context, the word is treated with deep respect and concern for the individual's well-being.

Another place you'll hear this word is in the insurance industry. Life insurance (Seimei Hoken) and specialized cancer insurance (Gan Hoken) are big business in Japan. Sales agents often use 前立腺がん as a primary example of why one needs coverage, citing its high incidence rate among men. You will see the word in bold letters on insurance application forms and marketing flyers. In these instances, the word is used to evoke a sense of 'risk management' (Risk kanri). It is also discussed in corporate HR departments when managing 'work-life balance' for employees undergoing long-term treatment, as many men continue to work while receiving hormone therapy or radiation.

Workplace Context

病気休暇 (Byōki kyūka - Sick leave) discussions often involve providing a diagnosis of 前立腺がん to HR.

Finally, the word is prevalent in the 'Silver Economy'—products and services aimed at the elderly. From specialized supplements to adult diapers (often needed post-surgery), the word 前立腺がん is a silent but pervasive presence in the marketing of elder care. Even in fiction, such as Medical Dramas (e.g., 'Doctor-X' or 'Shiroi Kyotō'), the word is used to create tension in the operating room. Whether it's a doctor discussing a 'difficult case' or a family member crying in a waiting room, the word is a staple of Japanese television drama, reflecting its real-world significance in Japanese life.

Public Figures

Many Japanese celebrities have publicly announced their struggle with 前立腺がん to encourage others to get tested.

For learners of Japanese, the most common mistakes involving 前立腺がん (Zenritsusen-gan) usually fall into three categories: pronunciation, kanji usage, and confusion with similar-sounding medical conditions. First, let's address pronunciation. The word Zenritsusen contains four morae (beats). A common mistake is to misplace the pitch or to skip the 'tsu' (っ) sound if it were a double consonant, but here it is a full 'tsu' (つ). Some learners also confuse it with Zenritsuzen (adding a 'zen' at the end), which is incorrect. The 'sen' (腺) must be clear, as it means gland. Pronouncing it as 'Zenritsusan' might make it sound like a person's name, which would be quite awkward in a medical context.

Pronunciation Pitfall

Mistaking 'Sen' (腺 - gland) for 'Zen' (前 - before) or 'San' (山 - mountain).

Second, kanji errors are frequent. The kanji for sen (腺) is relatively rare outside of medical terms. It consists of the 'flesh' radical (⾁) on the left and the phonetic 'izumi' (泉) on the right. Learners often forget the radical or try to write it with the 'ishi' (stone) radical. Furthermore, as mentioned before, writing the 'gan' part as 癌 is technically correct but can be seen as overly clinical or even 'scary' in a personal letter or a general brochure. Most modern Japanese writing favors the hiragana gan (がん). Using the wrong kanji for 'gan' (like 岩 - rock) is a comical but serious error that changes the meaning entirely.

A third major mistake is confusing 前立腺がん with 前立腺肥大症 (Zenritsusen hidaishō). While both involve the prostate, they are very different medical conditions. Using 'gan' when you mean 'enlargement' (hidai) can cause unnecessary panic. Another similar-sounding word is Zenritsusen-en (前立腺炎 - Prostatitis/Inflammation of the prostate). Learners often mix up the suffixes -gan (cancer), -en (inflammation), and -shō (syndrome/illness). In a medical setting, precision is paramount, so confusing these can lead to significant misunderstandings with medical staff.

Confusion Alert

前立腺がん (Cancer) vs. 前立腺炎 (Inflammation/Prostatitis). The difference is just one syllable ('gan' vs. 'en').

Finally, there's the 'social mistake' of being too direct. In Japanese culture, people often use euphemisms for cancer, like "O-mune no byōki" (a chest illness) for breast cancer or simply "Warui mono" (a bad thing) when a diagnosis is first suspected. While 前立腺がん is the correct term, blurting it out in a crowded room or to someone you don't know well might be considered insensitive. It is better to use a lead-in phrase like "Zetsubōteki na hanashi de wa nai no desu ga..." (It's not a hopeless story, but...) or to wait for the other person to use the term first. Context and 'reading the air' (kūki o yomu) are just as important as the vocabulary itself.

Grammar Check

Remember that you 'have' or 'are diagnosed with' cancer using 'ni naru' or 'to shindan sareru'. You are not the cancer itself.

When discussing 前立腺がん (Zenritsusen-gan), it's helpful to know related terms that might be used as alternatives or to provide more specific detail. The most common alternative is the more general 前立腺の悪性腫瘍 (Zenritsusen no akusei shuyō), which translates to 'malignant tumor of the prostate.' This is a more formal, clinical way to say the same thing. Doctors might use this in official medical reports to be precise about the nature of the growth. Conversely, a 'benign tumor' would be ryōsei shuyō (良性腫瘍). Knowing the difference between akusei (malignant) and ryōsei (benign) is vital for any medical discussion in Japanese.

Comparison: Cancer vs. Tumor

前立腺がん: Common, direct term for the disease.
前立腺の悪性腫瘍: Technical, used in formal medical contexts.

Another related term is 前立腺肥大症 (Zenritsusen hidaishō), or Benign Prostatic Hyperplasia (BPH). While not cancer, it is the most common reason men visit a urologist with similar symptoms (difficulty urinating). In conversation, people often start by saying they have Zenritsusen hidai and then clarify whether it has turned into gan. Another term is PSA chi (PSA levels). Often, people don't say they have cancer yet; they say, "PSA no atai ga takai" (My PSA values are high), which is the precursor to the 'gan' discussion. This euphemistic or indirect approach is very common in the early stages of diagnosis.

In terms of stage and severity, you might hear Sōki-gan (早期がん - early-stage cancer) versus Shinkō-gan (進行がん - advanced/progressive cancer). These are essential qualifiers. If the cancer has spread, the word Ten'i (転移 - metastasis) is used. For example, "Kotsu-ten'i" (bone metastasis) is a common complication of advanced 前立腺がん. In the realm of treatment, you'll hear Zenseki (全摘 - total removal/prostatectomy) or Hōshasen chiryō (放射線治療 - radiation therapy). These words often follow the mention of 前立腺がん to describe the next steps. Understanding this 'vocabulary family' helps you follow the narrative of a patient's journey.

Comparison: Stages

早期がん (Sōki-gan): Early stage, often treatable.
末期がん (Makki-gan): Terminal stage cancer.

Lastly, consider the word Shuyō mākā (腫瘍マーカー - tumor marker). This is the general category that PSA falls into. While 前立腺がん is the specific diagnosis, many patients will talk about their 'marker levels' as a way to track their progress. In support groups, you might also hear the term Sabaibā (サバイバー - survivor), borrowed from English, or the more traditional Tōbyō-chū (闘病中 - currently fighting a disease). These terms provide the emotional and social context surrounding the medical word. By learning these alternatives, you can communicate more nuanced thoughts about health and illness in Japanese.

Important Suffix

-中 (-chū) - Meaning 'in the middle of'. Used as 'Tōbyō-chū' (fighting a disease) or 'Chiryō-chū' (undergoing treatment).